incarceration

Review of Alternatives to Incarceration Efforts Worldwide

Citation
Diplomacy Lab Project 2010304, U.S. Department of State, Secretary’s Office of Global Partnerships and Bureau of International Narcotics and Law Enforcement Affairs and John Jay College of Criminal Justice
Publication Date

Substance use disorders are reoccurring chronic, often relapsing disease that affect the brain and should be treated within the public health arena similar to other diseases such as diabetes and heart disease. This understanding, however, does not easily find its way into public or social policy.

Periods of altered risk for non-fatal drug overdose

Citation
Keen, C., Kinner, S. A., Young, J. T., Snow, K., Zhao, B., Gan, W., & Slaunwhite, A. K. (2021). Periods of altered risk for non-fatal drug overdose: a self-controlled case series. The Lancet Public Health, 6(4), e249-e259. Chicago

The risk of an individual overdosing is influenced by a range of, often overlapping circumstances. Factors such as incarceration, mental and physical health conditions, and the treatments prescribed for these conditions can all affect the risk of overdose.

This study, published in The Lancet Public Health, aimed to: 

Use of Medication-Assisted Treatment for Opioid Use Disorder in Criminal Justice Settings

Created by
The Substance Abuse and Mental Health Services Administration (SAMHSA)
Publication Date

The success of treatment and recovery of individuals with opioid use disorder (OUD) can vary. Most often, a combination of factors adds complexities to evaluating the effectiveness of services and interventions.

Utilization of Addiction Treatment among U.S. Adults with History of Incarceration and Substance Use Disorders

Citation
Tsai and Gu Addict Sci Clin Pract (2019) 14:9 https://doi.org/10.1186/s13722-019-0138-4
Publication Date

Abstract

Background

The high prevalence of substance use disorders (SUDs) among incarcerated adults in the U.S. is well-known, but there has been less examination of SUD treatment and rates of incarceration among the population of adults with SUDs as the denominator.

A Randomized, Open Label Trial of Methadone Continuation versus Forced Withdrawal in a Combined US Prison and Jail

Citation
Brinkley-Rubinstein, L et al. (2018). A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release. Drug & Alcohol Dependence , Volume 184 , 57 - 63
Publication Date

Highlights

  • MMT during incarceration leads to lower injection drug and heroin use.
  • MMT during incarceration leads to fewer non-fatal overdoses.
  • MMT during incarceration leads to higher rates of engagement in treatment.

Abstract

Recently incarcerated individuals are at increased risk of opioid overdose.